Akari TherapeuticsAKTX
13F holders, Q4 2024 (December 31)14holders +4
4new positions
1sold out
1famous investor
$1.22avg. 13F price*
At the end of Q4 2024, 14 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings, up 4 from Q3 2024. 4 opened new positions and 1 sold out. The largest holders were Palo Alto Investors LP ($178K), Omnia Family Wealth, LLC ($107K) and Cerity Partners LLC ($29K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $207K |
| Exits | 1 | $99K |
All 13F filers, Q3 2024 → Q4 2024: 174,719 shares bought and 33,262 shares sold, net +141,457 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Palo Alto Investors LP | 0.03% | New | 146,024 | $178K |
| Omnia Family Wealth, LLC | 0.04% | No change | 87,628 | $107K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $29K |
| Renaissance Technologies | 0.00% | Add +29.9% | 23,465 | $29K |
| Cresset Asset Management, LLC | 0.00% | No change | 18,408 | $22K |
| Catalina Capital Group, LLC | 0.01% | New | 13,105 | $16K |
| Accent Capital Management, LLC | 0.01% | New | 10,000 | $12K |
| UBS Group AG | 0.00% | New | 194 | $237 |
| Bank of America Corp. | 0.00% | No change | 150 | $183 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $122 |
| Truvestments Capital LLC | 0.00% | No change | 50 | $61 |
| Morgan Stanley | 0.00% | Reduce -25.0% | 6 | $7 |
| Cornerstone Planning Group LLC | 0.00% | No change | 5 | $6 |
| SBI Securities Co., Ltd. | 0.00% | — | 5 | $6 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.